CDK2 and central nervous system cancer: Taken together, we propose that HSP90AA1-IT1, a potential oncogenic lncRNA, performs its function in part via regulating miR-885-5p-CDK2 signaling axis, which would provide a new therapeutic perspective on targeting gliomas.